Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / May / Nextgeneration Graft Health Monitoring
Clinical care Liquid biopsy Omics Screening and monitoring Molecular Pathology Voices in the Community

Next-generation Graft Health Monitoring

Donor-derived cell-free DNA represents a new approach to an old problem in heart transplantation

By Stephanie Anderson 05/04/2026 Technology 4 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Transplant Surgery

Institutions were ranked based on their leadership in noninvasive biomarkers, molecular diagnostics, clinical trial activity, peer-reviewed publications, and overall national reputation in transplant surgery.

  • #1

    Stanford Health Care–Stanford Hospital and Stanford University School of Medicine

    Palo Alto, CA

    Stanford is a pioneer in noninvasive monitoring techniques, particularly in heart transplantation, and has significant NIH-backed research initiatives.

    Key Differentiators

    • Transplant Surgery
  • #2

    Cedars-Sinai Medical Center (Smidt Heart Institute and Comprehensive Transplant Center)

    Los Angeles, CA

    Cedars-Sinai combines high transplant volumes with innovative research on dd-cfDNA, contributing significantly to clinical evidence in transplantation.

    Key Differentiators

    • Transplant Surgery
  • #3

    Hospitals of the University of Pennsylvania–Penn Presbyterian (Penn Medicine)

    Philadelphia, PA

    Penn Medicine led the DART study validating dd-cfDNA assays in kidney transplantation, showcasing their commitment to advancing noninvasive monitoring.

    Key Differentiators

    • Transplant Surgery

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Anderson

Stephanie Anderson, Product Manager – HT Genomics, Promega, UK

More Articles by Stephanie Anderson

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.